{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-10-22",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "product_ndc": "59651-785",
      "generic_name": "Oxcarbazepine",
      "labeler_name": "Aurobindo Pharma Limited",
      "brand_name": "Oxcarbazepine",
      "active_ingredients": [
        {
          "name": "OXCARBAZEPINE",
          "strength": "150 mg/1"
        }
      ],
      "finished": true,
      "packaging": [
        {
          "package_ndc": "59651-785-01",
          "description": "100 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (59651-785-01)",
          "marketing_start_date": "20261016",
          "sample": false
        }
      ],
      "listing_expiration_date": "20271231",
      "openfda": {},
      "marketing_category": "ANDA",
      "dosage_form": "TABLET, FILM COATED, EXTENDED RELEASE",
      "spl_id": "6e11231c-bc13-42e1-ac5e-097709d8b35d",
      "product_type": "HUMAN PRESCRIPTION DRUG",
      "route": [
        "ORAL"
      ],
      "marketing_start_date": "20261016",
      "product_id": "59651-785_6e11231c-bc13-42e1-ac5e-097709d8b35d",
      "application_number": "ANDA219241",
      "brand_name_base": "Oxcarbazepine",
      "pharm_class": [
        "Anti-epileptic Agent [EPC]",
        "Decreased Central Nervous System Disorganized Electrical Activity [PE]"
      ]
    }
  ]
}